had to be closed according to government policy. But the company was able to adjust to its profitable operating results this quarter details as follows: Management Discussion and Analysis Q2/2020 Page 3
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
Gross Profit Selling Admin Net(loss) profit Q1/17 212,140 78,137 19,861 24,659 21,584 Q1/18 213,552 76,707 21,974 18,709 27,898 % Change 0.67 (1.83) 10.64 (24.13) 29.25 In overall, the Company and its
date on January 1, 2020. By this summarization of business operation and financial statement of year 2019 was prepared under standard before the change and does not have retrospective improvements on
three years or upon occurrence of a widespread adverse incident; (2) To adjust the submission schedule for the Risk Level Assessment (RLA) report and IT audit report to be within the same period (during
liabilities stood at THB 7,174.9mn • Debt to Equity ratio stood at 1.04 times as of 31 December 2019, decreased from 1.14 times as at end of 2018 Change in accounting policies and reclassification in 2019
a fair price from the date of the change, the proportion of investment. By recognized profit on changes in the proportion of investment in the period of 9 months in year 2017 amount 6.84 million baht
The Securities and Exchange Commission (SEC) held a meeting with the Department of Climate Change and Environment (DCCE), the Ministry of Natural Resources and Environment (MNRE), the Thailand
PUBLIC COMPANY LIMITED Disclosure Business News ( 4 record(s) found) Date Time Heading Link 17/08/2020 18:07 Notification of the Resolutions of the Board of Directors Approving Change of Interim Dividend
adjust the assumptions for cash flows projections of those subsidiaries to calculate the recoverable amount appropriately, and to consider the adequacy and appropriateness of the impairment loss for